Methods for operating polyethylene reactor systems
US-2024392119-A1 · Nov 28, 2024 · US
US2018086902A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2018086902-A1 |
| Application number | US-201715711646-A |
| Country | US |
| Kind code | A1 |
| Filing date | Sep 21, 2017 |
| Priority date | Sep 26, 2016 |
| Publication date | Mar 29, 2018 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Components of medical devices include polyethylene-poly(ethylene oxide) amphiphilic graft copolymers (PE-g-PEO) in their base polymer formulations. The base polymeric formulations comprise at least a polymer or co-polymer of ethylene. These components are suitable for solvent-bonding with other components and enhance bond strength of the medical devices.
Opening claim text (preview).
What is claimed is: 1 . A tubing for a medical device formed from a blend comprising: a base polymeric formulation comprising at least a polymer or co-polymer of ethylene or propylene and excluding free poly(ethylene oxide); and an additive comprising a polyethylene-poly(ethylene oxide) amphiphilic graft copolymer (PE-g-PEO); the PE-g-PEO being present in the blend in an amount in the range of about 0.01 to about 5.0% by weight of the blend. 2 . The tubing of claim 1 , wherein the PE-g-PEO is according to Formula (I): wherein R is hydrogen, alkyl, substituted alkyl, vinylic substituted alkyl, hydrocarbyl, substituted hydrocarbyl, or vinylic substituted hydrocarbyl group; the molar value of m is in the range from 2 to 40 mole percent; the molar value of n is in the range from 60 to 98 mole percent; and p is in the range from 5 to 500 ethylene oxide units. 3 . The tubing of claim 1 , wherein the base polymeric formulation comprises polyethylene, polypropylene, a polyethylene-polypropylene co-polymer, a polyethylene- and/or polypropylene-containing thermoplastic elastomer (TPE), or combinations thereof. 4 . The tubing of claim 3 , wherein the base polymeric formulation comprises a co-polymer of polyethylene and polypropylene. 5 . The tubing of claim 3 , wherein the polyethylene-and/or polypropylene-containing thermoplastic elastomer (TPE) comprises at least 60 mol % total polyethylene and/or polypropylene. 6 . The tubing of claim 1 , wherein the PE-g-PEO is a product of ethylene oxide ring-opening polymerization of an ethylene vinyl acetate copolymer having from 10 to 40 weight percent of vinyl acetate. 7 . The tubing of claim 1 , wherein the PE-g-PEO has a dispersity index in the range of 2 to 10. 8 . A medical device comprising: a tubing comprising a polymeric blend comprising a base polymeric formulation comprising at least a polymer or co-polymer of ethylene or propylene and excluding free poly(ethylene oxide), and an additive comprising a polyethylene-poly(ethylene oxide) amphiphilic graft copolymer (PE-g-PEO) according to Formula (I): wherein R is hydrogen, alkyl, substituted alkyl, vinylic substituted alkyl, hydrocarbyl, substituted hydrocarbyl, or vinylic substituted hydrocarbyl group; the molar value of m is in the range from 2 to 40 mole percent; the molar value of n is in the range from 60 to 98 mole percent; and p is in the range from 5 to 500 ethylene oxide units; wherein the PE-g-PEO is present in the blend in an amount in the range of about 0.01 to about 5.0% by weight of the blend; and a connector bonded to the tubing; wherein the PE-g-PEO is effective to enhance bonding of the tubing to a connector. 9 . The medical device of claim 8 , wherein the base polymeric formulation comprises polyethylene, polypropylene, a polyethylene-polypropylene co-polymer, a polyethylene- and/or polypropylene-containing thermoplastic elastomer (TPE), or combinations thereof. 10 . The medical device of claim 8 , wherein the base polymeric formulation comprises a co-polymer of polyethylene and polypropylene. 11 . The medical device of claim 8 , wherein the polyethylene-and/or polypropylene-containing thermoplastic elastomer (TPE) comprises at least 60 mol % polyethylene and/or polypropylene. 12 . The medical device of claim 8 , wherein the PE-g-PEO is a product of ethylene oxide ring-opening polymerization of an ethylene vinyl acetate copolymer having from 10 to 40 weight percent of vinyl acetate. 13 . The medical device of claim 8 , wherein the connector comprises a polar material. 14 . The medical device of claim 13 , wherein the polar material selected from the group consisting of: poly(methyl methacrylate) (PMMA), styrene maleic anhydride (SMA), polycarbonate (PC), and methyl methacrylate-acrylonitrile-butadiene-styrene (MABS). 15 . The medical device of claim 8 , wherein the connector is solvent-bonded to the tubing. 16 . A method of making a medical device comprising: obtaining a polyethylene-poly(ethylene oxide) amphiphilic graft copolymer (PE-g-PEO); combining the PE-g-PEO with a base polymeric formulation comprising at least a polymer or co-polymer of ethylene or propylene and excluding free poly(ethylene oxide) to form a blend, the PE-g-PEO being present in the blend in an amount in the range of about 0.01 to about 5.0% by weight of the blend; forming a tubing from the blend; and bonding the tubing to a connector in the presence of a solvent to form the medical device; wherein the PE-g-PEO is effective to enhance bonding of the tubing to a connector. 17 . The method of claim 16 , wherein ethylene oxide ring-opening polymerization of an ethylene vinyl acetate copolymer having from 10 to 40 weight percent of vinyl acetate is used to form the PE-g-PEO, which is according to Formula (I): wherein R is hydrogen, alkyl, substituted alkyl, vinylic substituted alkyl, hydrocarbyl, substituted hydrocarbyl, or vinylic substituted hydrocarbyl group; the molar value of m is in the range from 2 to 40 mole percent; the molar value of n is in the range from 60 to 98 mole percent; and p is in the range from 5 to 500 ethylene oxide units. 18 . The method of claim 16 , wherein the base polymeric formulation comprises polyethylene, polypropylene, a polyethylene-polypropylene co-polymer, a polyethylene- and/or polypropylene-containing thermoplastic elastomer (TPE), or combinations thereof. 19 . The method of claim 16 , wherein the base polymeric formulation comprises a co-polymer of polyethylene and polypropylene. 20 . The method of claim 16 , wherein the polyethylene-and/or polypropylene-containing thermoplastic elastomer (TPE) comprises at least 60 mol % polyethylene and/or polypropylene.
Polyethylene · CPC title
LDPE (radical process) · CPC title
used for pipes · CPC title
specially adapted for joining pipes of dissimilar materials {(joints between metal and plastic pipes F16L47/24)} · CPC title
Mixtures of macromolecular compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.